合成致死性情報に基づいたがん治療薬の再利用における課題と機会
Michael Vermeulen1, Andrew W Craig2,3, Tomas Babak4,5
1Department of Biology, Queen's University, Kingston, ON, Canada. 0mcv@queensu.ca.
NPJ systems biology and applications
|December 13, 2025
まとめ
合成致死性は、腫瘍抑制遺伝子変異によるがんの脆弱性を標的とする。研究者たちは薬剤の再利用の機会を特定したが、遺伝的効果と薬剤効果はしばしば異なることが判明し、新たな評価方法が必要である。
科学分野:
- 腫瘍学
- ゲノム学
- 薬理学
背景:
- がんの3分の2は腫瘍抑制遺伝子の変異に起因するが、標的療法は依然として乏しい。
- 合成致死性は、がん特異的な脆弱性を利用するための有望な戦略を提供する。
- 新しいがん治療法の開発には、信頼性の高い合成致死性相互作用の特定が不可欠である。
主な方法:
- Cancer Dependency MapからのゲノムワイドCRISPR/Cas9ノックアウト(KO)生存率スクリーニングデータを解析した。
- 患者腫瘍における相互排他性を用いて相互作用の臨床的関連性を評価した。
- 遺伝子KO効果を模倣する阻害剤を特定するために、薬剤感受性データを統合した。
結論:
- 合成致死性は、がんの依存性と治療標的を特定するための実行可能な戦略である。
- 遺伝子スクリーニングに基づく薬剤再利用は有望であるが、慎重な検証が必要である。
- 遺伝的摂動と薬理学的摂動の間には根本的な違いが存在するため、特定の変異に関連する薬剤の効果を評価するための新しいアプローチが必要である。
さらに関連する動画
14:51Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
3.5K
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
11.1K
関連する概念動画
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
